Effect of Topotecan on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By Nielsen H.A.   Nielsen D.   Engelholm S.A.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite

Effects of Paclitaxel on CA-125 Serum Levels in Ovarian Cancer Patients

By Paulsen T.   Marth C.   Kaern J.   Nustad K.   Kristensen G.B.   Trope C.  

Gynecologic Oncology, Vol. 76, Iss. 3, 2000-03 ,pp. : 326-330

Elsevier

Access to resources Recommend Favorite

Can Serum CA-125 Levels Predict the Optimal Primary Cytoreduction in Patients with Advanced Ovarian Carcinoma?

By Saygili U.   Guclu S.   Uslu T.   Erten O.   Demir N.   Onvural A.  

Gynecologic Oncology, Vol. 86, Iss. 1, 2002-07 ,pp. : 57-61

Academic Press

Access to resources Recommend Favorite

Effect of Low-Dose Oral Etoposide on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer

By de Jong R.S.   Hofstra L.S.   Willemse P.H.B.   de Bruijn H.W.A.   de Vries E.G.E.   Boonstra H.   Mulder N.H.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 197-201

Elsevier

Access to resources Recommend Favorite

Serum, Pleural Effusion, and Ascites CA-125 Levels in Ovarian Cancer and Nonovarian Benign and Malignant Diseases: A Comparative Study

By Topalak O.   Saygili U.   Soyturk M.   Karaca N.   Batur Y.   Uslu T.   Erten O.  

Gynecologic Oncology, Vol. 85, Iss. 1, 2002-04 ,pp. : 108-113

Elsevier

Access to resources Recommend Favorite